These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30250143)

  • 1. MitoTALEN reduces mutant mtDNA load and restores tRNA
    Bacman SR; Kauppila JHK; Pereira CV; Nissanka N; Miranda M; Pinto M; Williams SL; Larsson NG; Stewart JB; Moraes CT
    Nat Med; 2018 Nov; 24(11):1696-1700. PubMed ID: 30250143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.
    Hashimoto M; Bacman SR; Peralta S; Falk MJ; Chomyn A; Chan DC; Williams SL; Moraes CT
    Mol Ther; 2015 Oct; 23(10):1592-9. PubMed ID: 26159306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo.
    Gammage PA; Viscomi C; Simard ML; Costa ASH; Gaude E; Powell CA; Van Haute L; McCann BJ; Rebelo-Guiomar P; Cerutti R; Zhang L; Rebar EJ; Zeviani M; Frezza C; Stewart JB; Minczuk M
    Nat Med; 2018 Nov; 24(11):1691-1695. PubMed ID: 30250142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating Mitochondrial DNA Heteroplasmy with Mitochondrially Targeted Endonucleases.
    Mikhailov N; Hämäläinen RH
    Ann Biomed Eng; 2024 Sep; 52(9):2627-2640. PubMed ID: 36001180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further pitfalls in the diagnosis of mtDNA mutations: homoplasmic mt-tRNA mutations.
    Tuppen HA; Fattori F; Carrozzo R; Zeviani M; DiMauro S; Seneca S; Martindale JE; Olpin SE; Treacy EP; McFarland R; Santorelli FM; Taylor RW
    J Med Genet; 2008 Jan; 45(1):55-61. PubMed ID: 18178636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases.
    Lee S; Lee H; Baek G; Namgung E; Park JM; Kim S; Hong S; Kim JS
    Genome Biol; 2022 Oct; 23(1):211. PubMed ID: 36224582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
    Bacman SR; Williams SL; Pinto M; Peralta S; Moraes CT
    Nat Med; 2013 Sep; 19(9):1111-3. PubMed ID: 23913125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo.
    Zekonyte U; Bacman SR; Smith J; Shoop W; Pereira CV; Tomberlin G; Stewart J; Jantz D; Moraes CT
    Nat Commun; 2021 May; 12(1):3210. PubMed ID: 34050192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mitoTev-TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels.
    Pereira CV; Bacman SR; Arguello T; Zekonyte U; Williams SL; Edgell DR; Moraes CT
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30012581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.
    Nissanka N; Moraes CT
    EMBO Rep; 2020 Mar; 21(3):e49612. PubMed ID: 32073748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
    Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
    Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmitochondrial mice as models for primary prevention of diseases caused by mutation in the tRNA(Lys) gene.
    Shimizu A; Mito T; Hayashi C; Ogasawara E; Koba R; Negishi I; Takenaga K; Nakada K; Hayashi J
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3104-9. PubMed ID: 24510903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategies towards therapeutic manipulation of mtDNA heteroplasmy.
    Pereira CV; Moraes CT
    Front Biosci (Landmark Ed); 2017 Jan; 22(6):991-1010. PubMed ID: 27814659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring.
    Hellebrekers DM; Wolfe R; Hendrickx AT; de Coo IF; de Die CE; Geraedts JP; Chinnery PF; Smeets HJ
    Hum Reprod Update; 2012 Jul; 18(4):341-9. PubMed ID: 22456975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy.
    Taylor RW; Giordano C; Davidson MM; d'Amati G; Bain H; Hayes CM; Leonard H; Barron MJ; Casali C; Santorelli FM; Hirano M; Lightowlers RN; DiMauro S; Turnbull DM
    J Am Coll Cardiol; 2003 May; 41(10):1786-96. PubMed ID: 12767666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model.
    Bacman SR; Williams SL; Hernandez D; Moraes CT
    Gene Ther; 2007 Sep; 14(18):1309-18. PubMed ID: 17597792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmitochondrial mice as models for mitochondrial DNA-based diseases.
    Nakada K; Hayashi J
    Exp Anim; 2011; 60(5):421-31. PubMed ID: 22041279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice.
    Safdar A; Khrapko K; Flynn JM; Saleem A; De Lisio M; Johnston AP; Kratysberg Y; Samjoo IA; Kitaoka Y; Ogborn DI; Little JP; Raha S; Parise G; Akhtar M; Hettinga BP; Rowe GC; Arany Z; Prolla TA; Tarnopolsky MA
    Skelet Muscle; 2016; 6():7. PubMed ID: 26834962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease.
    Kauppila JHK; Baines HL; Bratic A; Simard ML; Freyer C; Mourier A; Stamp C; Filograna R; Larsson NG; Greaves LC; Stewart JB
    Cell Rep; 2016 Sep; 16(11):2980-2990. PubMed ID: 27626666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.